Replies to post #236741 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

The first related to the sugen agreement the second to tpn. Hardly big players

[lasers]

Form CT ORDER ELITE PHARMACEUTICALS
10K WIZARD 5:17 PM ET 12/22/2016
http://archive.fast-edgar.com/20161222/ARZ2T2ZZZVQZC2ZZZP2PWBZZIL9ALZ6RZ2Z2

Filed on: December 22, 2016

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
DECEMBER 22, 2016
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Elite Pharmaceuticals, Inc.
File No. 001-15697 - CF#34443
_____________________
Elite Pharmaceuticals, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on November 9, 2016.

Based on representations by Elite Pharmaceuticals, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibits will not be released to the public for the time periods specified:

Exhibit 10.44 through November 9, 2022

Exhibit 10.46 through November 9, 2019

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Brent J. Fields
Secretary

####

From the 10-Q


10.44

August 24, 2016 Master Development and License Agreement between Elite and SunGen Pharma LLC. Confidential portions of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.**

10.46

July 20, 2015 Third Amendment to TPN-Elite Manufacturing and Supply Agreement dated June 23, 2011. Confidential portion of this exhibit have been redacted and filed separately with the Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended.**

http://ir.elitepharma.com/profiles/investor/secDL.asp?c=1053369&ID=000114420416132825/0001144204-16-132825#LoadingArea

Filing Date
2016-11-09